Dermatofibrosarcoma protuberans of the breast: A rare diagnosis requiring aggressive initial surgical therapy

Abstract

Dermatofibrosarcoma protuberans (DFSP) is an extremely rare cutaneous neoplasm of the dermal layer of the skin and is histologically classified as a sarcoma. DFSP itself has an incidence of 0.8 cases per million annually. It accounts for 1% of all soft tissue sarcomas and less than 0.1% of all malignancies. DFSP has a high rate of local recurrence especially if there are positive margins on excision, but only up to 4% develop metastasis. Most reported cases are located in the trunk, extremities and head especially scalp. However, DFSP of the breast is very rare with very few reported in the literature. We report a case of a 33-year-old woman who presented with a histological diagnosis of DFSP of the breast, based on incisional biopsy. We report this case which highlights the important aspects in evaluating DFSP in the breast as well as its treatment.

Keywords

Dermatofibrosarcoma / protuberans

CONFLICTS OF INTEREST DISCLOSURE

The authors declare they have no conflicts of interest.

References

[1] McLoughlin PM, Girach M, Wood GA. Dermatofibrosarcoma protu-berans of the scalp. British Journal of Oral and Maxillofacial Surgery. 1992; 30: 401-403. https://doi.org/10.1016/0266-4356(92)90211-Z

[2] Bulliard C, Murali R, Chang LY, et al. Subcutaneous dermatofi-brosarcoma protuberans in skin of the breast: may mimic a primary breast lesion. Pathology. 2007; 39(4): 446-448. PMid: 17676490. https://doi.org/10.1080/00313020701444523

[3] Bowne WB, Antonescu CR, Leung DH. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000; 88: 2711-2720. https://doi.org/10.1002/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M

[4] Kreicher KL, Kurlander DE, Gittleman HR, et al. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States. Dermatological Surgery. 2016; 42 Suppl 1: S24-31. PMid: 26730971. https://doi.org/10.1097/DSS.0000000000000300

[5] Bowne WB, Antonescu CR, Leung DH. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000; 88: 2711-2720. https://doi.org/10.1002/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M

[6] McLoughlin PM, Girach M, Wood GA. Dermatofibrosarcoma pro-tuberans of the scalp. British Journal of Oral Maxillofacial Surgery. 1992; 30: 401-403. https://doi.org/10.1016/0266-4356(92)90211-Z

[7] Dragoumis DM, Katsohi LA, Amplianitis IK, et al. Late local re-currence of dermatofibrosarcoma protuberans in the skin of female breast. World Journal of Surgical Oncology. 2010; 8: 48. PMid: 20525288. https://doi.org/10.1186/1477-7819-8-48

[8] Miller SJ, Alam M, Andersen J. Dermatofibrosarcoma protuberans. Journal of the National Comprehensive Cancer Network. 2007; 5: 550-555. PMid: 17509257. https://doi.org/10.6004/jnccn.2007.0048

[9] Wacker J, Khan-Durani B, Hartschuh W. Modified mohs micro-graphic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Annals of Surgical Oncology. 2004; 11: 438-444. PMid: 15070606. https://doi.org/10.1245/ASO.2004.06.014

[10] Dragoumis DM, Katsohi LA, Amplianitis IK, et al. Late local re-currence of dermatofibrosarcoma protuberans in the skin of female breast. World Journal of Surgical Oncology. 2010; 8: 48. PMid: 20525288. https://doi.org/10.1186/1477-7819-8-48

[11] Nishio J, Iwasaki H, Ishiguro M. Supernumerary ring chromosome in a bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis. Genes Chromosomes and Cancer. 2001; 30: 305- 09. https://doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1091>3.0.CO;2-R

[12] Lemm D, Mugge LO, Mentzel T, et al. Current treatment options in dermatofibrosarcoma protuberans. Journal of Cancer Research and Clinical Oncology. 2009; 135: 653-665. PMid: 19205737. https://doi.org/10.1007/s00432-009-0550-3

[13] Mentzel T, Beham A, Katenkamp D, et al. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. American Journal of Surgical Pathology. 1998; 22: 576-587. PMid: 9591728. https://doi.org/10.1097/00000478-199805000-00009

[14] Roses DF, Valensi Q, LaTrenta G, et al. Surgical treatment of der-matofibrosarcoma protuberans. Surgery, Gynecology and Obstetrics. 1986; 162: 449-452. PMid: 3704900.

[15] Labropoulos SV, Razis ED. Imatinib in the treatment of dermatofi-brosarcoma protuberans. Biologics: Targets & Therapy. 2007; 1(4): 347-353. PMid: 19707305.